News – Page 977 – Endpoints News

Under pressure, drugmakers dilute price hikes, but nothing is set in stone just yet — report

7 years ago

Two years and $78M later, Amgen washes its hands of Advaxis' I/O drug — and shares plummet

7 years ago

This is the FDA’s year to shine, but can biopharma keep up as regulators continue to rev up chart-topping numbers?

7 years ago

Mylan claims win in Lantus patent battle, but legal war with Sanofi is far from over

7 years ago

Lilly, Incyte's baricitinib wins fast-track status for hard-to-treat lupus; Synthorx hammers out $150M+ IPO

7 years ago

Biogen shrugs off $1B-plus gene therapy pact after PhI/II implosion — AGTC shares crater

7 years ago

Flagship-backed Foghorn woos Bristol-Myers vet Carl Decicco to direct its 'gene traffic control' platform

7 years ago

A new analysis spotlights the top 20 drugs in the late-stage pipeline

7 years ago

Third Rock, Takeda-backed Ambys ushers in ex-NGM Bio president Jeff Jonker as CEO

7 years ago

Who needs venture backers? Bill Haney bags new deal cash from Celgene as his biotech upstart Dragonfly explores NK ...

7 years ago

WuXi AppTec cruises toward a steady debut in Hong Kong stock exchange, ending flat on IPO price

7 years ago

Another one of Bob Langer's MIT postdocs scores a biotech deal, auctioning his startup for up to $415M

7 years ago

'Idea Man' Paul Allen leaves behind plan to unscramble human immunology

7 years ago

Art Krieg moves from CEO post to CSO at Checkmate; Indivior breathes sigh of relief after court ruling

7 years ago

Upstart Akero continues its swoosh into NASH space with $70M windfall round

7 years ago

Mallinckrodt's woes persist as reformulated opioid painkiller fails to pass FDA muster

7 years ago

Shinichi Tamura reclaims the helm at Sosei as CEO Peter Bains hits the exit

7 years ago

In a repeat setback, Neurocrine flags a failure for Tourette syndrome study — shares sink

7 years ago

J&J beats Novartis' blockbuster rival in a head-to-head showdown over the psoriasis market

7 years ago

Bausch is keen on Synergy, after troubled constipation drug maker files for Chapter 11

7 years ago

FDA rolls out expectations for a looming regulatory shift for insulin and other biologics

7 years ago

Eli Lilly is going for it again, inking $2B Alzheimer's deal for tau therapies with AC Immune

7 years ago

Amgen enlists Entera in a drug discovery pact; Boehringer brings out the budget ax

7 years ago

Large coalition joins drug lobby in denouncing Trump proposal to import drug prices for Medicare

7 years ago

First page Previous page 974 975 976977978 979 980 Next page Last page